{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T19:38:27Z","timestamp":1772307507410,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.scr.2019.101536","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T11:44:31Z","timestamp":1565696671000},"page":"101536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Mesenchymal stem cells preserve their stem cell traits after exposure to antimetabolite chemotherapy"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6876-2074","authenticated-orcid":false,"given":"Ramon","family":"Lopez Perez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska","family":"M\u00fcnz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Vidoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"R\u00fchle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thuy","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonevisay","family":"Sisombath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingwen","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Wuchter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca-Ligia","family":"Grosu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Saffrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter E.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2550-1410","authenticated-orcid":false,"given":"Nils H.","family":"Nicolay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.scr.2019.101536_bb0005","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S1470-2045(16)30531-9","volume":"17","author":"Al-Batran","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.scr.2019.101536_bb0010","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/00001813-200409000-00010","article-title":"Non-toxic and short treatment with gemcitabine inhibits in vitro migration of HT-1080 cells","volume":"15","author":"Alcouffe","year":"2004","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.scr.2019.101536_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042908","article-title":"A mesenchymal stromal cell gene signature for donor age","volume":"7","author":"Alves","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.scr.2019.101536_bb0020","article-title":"5-FU for genital warts in non-immunocompromised individuals","author":"Batista","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.scr.2019.101536_bb0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/ten.teb.2013.0566","article-title":"Bone marrow mesenchymal stromal cells to treat complications following allogeneic stem cell transplantation","volume":"20","author":"Battiwalla","year":"2014","journal-title":"Tissue Eng. B Rev."},{"key":"10.1016\/j.scr.2019.101536_bb0030","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1200\/JCO.2002.11.149","article-title":"Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297","volume":"20","author":"Berlin","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.scr.2019.101536_bb0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1200\/JCO.1999.17.1.12","article-title":"Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer","volume":"17","author":"Cardenal","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.scr.2019.101536_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026241","article-title":"Bone marrow mesenchymal stem cells for improving hematopoietic function: an in vitro and in vivo model. Part 2: effect on bone marrow microenvironment","volume":"6","author":"Carrancio","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.scr.2019.101536_bb0045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.phrs.2004.01.006","article-title":"Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients","volume":"50","author":"Casale","year":"2004","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.scr.2019.101536_bb0050","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3109\/14653249.2010.501790","article-title":"Comparative study of stemness characteristics of mesenchymal cells from bone marrow of children and adults","volume":"12","author":"Choumerianou","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1016\/j.scr.2019.101536_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00280-016-3003-0","article-title":"Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective","volume":"78","author":"Ciccolini","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.scr.2019.101536_bb0060","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1586\/1744666X.2014.962996","article-title":"Methotrexate: an old new drug in autoimmune disease","volume":"10","author":"Cipriani","year":"2014","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.scr.2019.101536_bb0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.scr.2019.101536_bb0070","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.scr.2019.101536_bb0075","first-page":"83","article-title":"Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method","volume":"2","author":"Friedenstein","year":"1974","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.scr.2019.101536_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001132.pub2","article-title":"5-Fluorouracil for glaucoma surgery","author":"Green","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.scr.2019.101536_bb0085","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0006-2952(99)00035-0","article-title":"Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation","volume":"58","author":"Hatse","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.scr.2019.101536_bb0090","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1200\/JCO.1992.10.2.257","article-title":"A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck","volume":"10","author":"Jacobs","year":"1992","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.scr.2019.101536_bb0095","first-page":"135","article-title":"Comprehensive analysis of time- and dose-dependent patterns of gene expression in a human mesenchymal stem cell line exposed to low-dose ionizing radiation","volume":"19","author":"Jin","year":"2008","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.scr.2019.101536_bb0100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0065-2571(00)00011-X","article-title":"Importance of dihydropyrimidine dehydrogenase (DPD) deficiency in patients exhibiting toxicity following treatment with 5-fluorouracil","volume":"41","author":"Johnson","year":"2001","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.scr.2019.101536_bb0105","first-page":"1","article-title":"Antimetabolites","volume":"16","author":"Johnston","year":"1996","journal-title":"Cancer Chemother. Biol. Response Modif."},{"key":"10.1016\/j.scr.2019.101536_bb0110","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/bjc.1997.164","article-title":"Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damage","volume":"75","author":"Kinsella","year":"1997","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.scr.2019.101536_bb0115","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/jcmm.12972","article-title":"The effects of the DNA methyltranfserases inhibitor 5-Azacitidine on ageing, oxidative stress and DNA methylation of adipose derived stem cells","volume":"21","author":"Kornicka","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.scr.2019.101536_bb0120","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/jgm.1239","article-title":"Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice","volume":"10","author":"Kucerova","year":"2008","journal-title":"The Journal of Gene Medicine"},{"key":"10.1016\/j.scr.2019.101536_bb0125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.scr.2011.11.006","article-title":"Increased proliferation and chemosensitivity of human mesenchymal stromal cells expressing fusion yeast cytosine deaminase","volume":"8","author":"Kucerova","year":"2012","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.scr.2019.101536_bb0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.tox.2010.01.011","article-title":"p73alpha regulates the sensitivity of bone marrow mesenchymal stem cells to DNA damage agents","volume":"270","author":"Liang","year":"2010","journal-title":"Toxicology"},{"key":"10.1016\/j.scr.2019.101536_bb0135","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10616-011-9374-5","article-title":"Human adipose tissue derived mesenchymal stem cells are resistant to several chemotherapeutic agents","volume":"63","author":"Liang","year":"2011","journal-title":"Cytotechnology"},{"key":"10.1016\/j.scr.2019.101536_bb0140","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cyto.2005.11.003","article-title":"Cytokine interactions in mesenchymal stem cells from cord blood","volume":"32","author":"Liu","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.scr.2019.101536_bb0145","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.scr.2019.101536_bb0150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1478-811X-12-26","article-title":"Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential","volume":"12","author":"Lopatina","year":"2014","journal-title":"Cell Communication and Signaling"},{"key":"10.1016\/j.scr.2019.101536_bb0155","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1089\/scd.2010.0329","article-title":"TAp63alpha mediates chemotherapeutic agent-induced apoptosis in human bone marrow mesenchymal stem cells","volume":"20","author":"Lu","year":"2011","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.scr.2019.101536_bb0160","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.2018.4657","article-title":"Effect of intravesical instillation of gemcitabine vs saline immediately following resection of suspected low-grade non-muscle-invasive bladder cancer on tumor recurrence: SWOG S0337 randomized clinical trial","volume":"319","author":"Messing","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.scr.2019.101536_bb0165","doi-asserted-by":"crossref","first-page":"v7","DOI":"10.1093\/annonc\/mdj941","article-title":"Cellular pharmacology of gemcitabine","volume":"17","author":"Mini","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.scr.2019.101536_bb0170","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1634\/stemcells.2006-0108","article-title":"Presence of mesenchymal stem cells in human bone marrow after exposure to chemotherapy: evidence of resistance to apoptosis induction","volume":"24","author":"Mueller","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.scr.2019.101536_bb0175","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41598-017-18862-1","article-title":"Human mesenchymal stem cells lose their functional properties after paclitaxel treatment","volume":"8","author":"Munz","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.scr.2019.101536_bb0180","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fphar.2016.00172","article-title":"Colon cancer cells gene expression signature as response to 5- fluorouracil, oxaliplatin, and folinic acid treatment","volume":"7","author":"Negrei","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.scr.2019.101536_bb0185","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.ijrobp.2013.09.003","article-title":"Mesenchymal stem cells retain their defining stem cell characteristics after exposure to ionizing radiation","volume":"87","author":"Nicolay","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.scr.2019.101536_bb0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2015.06.012","article-title":"Mesenchymal stem cells - a new hope for radiotherapy-induced tissue damage?","volume":"366","author":"Nicolay","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.scr.2019.101536_bb0195","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.18632\/oncotarget.2857","article-title":"Mesenchymal stem cells are resistant to carbon ion radiotherapy","volume":"6","author":"Nicolay","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.scr.2019.101536_bb0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2016.02.007","article-title":"Mesenchymal stem cells exhibit resistance to topoisomerase inhibition","volume":"374","author":"Nicolay","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.scr.2019.101536_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/srep26645","article-title":"Mesenchymal stem cells are sensitive to bleomycin treatment","volume":"6","author":"Nicolay","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.scr.2019.101536_bb0210","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00066-016-0979-7","article-title":"High dose-rate endoluminal brachytherapy for primary and recurrent esophageal cancer: experience from a large single-center cohort","volume":"192","author":"Nicolay","year":"2016","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.scr.2019.101536_bb0215","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.biochem.75.103004.142443","article-title":"Ribonucleotide reductases","volume":"75","author":"Nordlund","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.scr.2019.101536_bb0220","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM199408253310803","article-title":"Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery","volume":"331","author":"O'Connell","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.scr.2019.101536_bb0225","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/jjco\/hyl067","article-title":"A phase I\/II study of combination chemotherapy with gemcitabine and 5-fluorouracil for advanced pancreatic cancer","volume":"36","author":"Okusaka","year":"2006","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.scr.2019.101536_bb0230","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.intimp.2013.12.022","article-title":"Gemcitabine-treated pancreatic cancer cell medium induces the specific CTL antitumor activity by stimulating the maturation of dendritic cells","volume":"19","author":"Pei","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.scr.2019.101536_bb0235","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0163-7258(00)00086-3","article-title":"Basis for effective combination cancer chemotherapy with antimetabolites","volume":"87","author":"Peters","year":"2000","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.scr.2019.101536_bb0240","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0925-4439(02)00082-0","article-title":"Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism","volume":"1587","author":"Peters","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.scr.2019.101536_bb0245","first-page":"3","article-title":"Gemcitabine: metabolism, mechanisms of action, and self-potentiation","volume":"22","author":"Plunkett","year":"1995","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.scr.2019.101536_bb0250","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1042\/CBI20110637","article-title":"Mesenchymal stem cells derived from different origins have unique sensitivities to different chemotherapeutic agents","volume":"36","author":"Qi","year":"2012","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.scr.2019.101536_bb0255","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.3892\/ijo.2012.1648","article-title":"Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition","volume":"41","author":"Quint","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.scr.2019.101536_bb0260","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood.V85.4.997.bloodjournal854997","article-title":"Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6\/E7 genes","volume":"85","author":"Roecklein","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.scr.2019.101536_bb0265","doi-asserted-by":"crossref","first-page":"87809","DOI":"10.18632\/oncotarget.21214","article-title":"Cisplatin radiosensitizes radioresistant human mesenchymal stem cells","volume":"8","author":"Ruhle","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.scr.2019.101536_bb0270","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1002\/ijc.31619","article-title":"The current understanding of mesenchymal stem cells as potential attenuators of chemotherapy-induced toxicity","volume":"143","author":"Ruhle","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.scr.2019.101536_bb0275","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.ijrobp.2018.01.015","article-title":"The radiation resistance of human multipotent mesenchymal stromal cells is independent of their tissue of origin","volume":"100","author":"Ruhle","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.scr.2019.101536_bb0280","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12015-019-09886-3","article-title":"The therapeutic potential of mesenchymal stromal cells in the treatment of chemotherapy-induced tissue damage","volume":"15","author":"Ruhle","year":"2019","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.scr.2019.101536_bb0285","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10517-012-1895-1","article-title":"Etoposide and hypoxia do not activate apoptosis of multipotent mesenchymal stromal cells in vitro","volume":"154","author":"Rylova","year":"2012","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.scr.2019.101536_bb0290","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12272-016-0878-6","article-title":"5-Fluorouracil inhibits cell migration by induction of Sestrin2 in colon cancer cells","volume":"40","author":"Seo","year":"2017","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.scr.2019.101536_bb0295","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1124\/mol.107.043372","article-title":"Inhibition of c-Myc down-regulation by sustained extracellular signal-regulated kinase activation prevents the antimetabolite methotrexate- and gemcitabine-induced differentiation in non-small-cell lung cancer cells","volume":"73","author":"Serra","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.scr.2019.101536_bb0300","article-title":"Effect of mesenchymal stem cells injection on induced stomatitis in chemotherapy treated rats","volume":"13","author":"Serry","year":"2017","journal-title":"Journal of American Science"},{"key":"10.1016\/j.scr.2019.101536_bb0305","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1741-7015-11-146","article-title":"Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells","volume":"11","author":"Siegel","year":"2013","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.scr.2019.101536_bb0310","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/stem.1222","article-title":"Multiple facets of The DNA damage response contribute to the radio-resistance of mouse mesenchymal stromal cell lines","volume":"31","author":"Sugrue","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.scr.2019.101536_bb0315","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1089\/scd.2013.0567","article-title":"Mesenchymal stem cell paracrine activity is modulated by platelet lysate: induction of an inflammatory response and secretion of factors maintaining macrophages in a proinflammatory phenotype","volume":"23","author":"Ulivi","year":"2014","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.scr.2019.101536_bb0320","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/340257","article-title":"Management of fibrosis: the mesenchymal stromal cells breakthrough","volume":"2014","author":"Usunier","year":"2014","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.scr.2019.101536_bb0325","first-page":"1178","article-title":"5-FU-injured bone marrow stromal cells initiate stress-induced premature senescence of hematopoietic cells","volume":"25","author":"Xiong","year":"2017","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.scr.2019.101536_bb0330","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1089\/scd.2011.0252","article-title":"Three-dimensional spheroid culture of human gingiva-derived mesenchymal stem cells enhances mitigation of chemotherapy-induced oral mucositis","volume":"21","author":"Zhang","year":"2011","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.scr.2019.101536_bb0335","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1089\/scd.2011.0252","article-title":"Three-dimensional spheroid culture of human gingiva-derived mesenchymal stem cells enhances mitigation of chemotherapy-induced oral mucositis","volume":"21","author":"Zhang","year":"2012","journal-title":"Stem Cells Dev."}],"container-title":["Stem Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1873506119301667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1873506119301667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:31:19Z","timestamp":1761737479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1873506119301667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":67,"alternative-id":["S1873506119301667"],"URL":"https:\/\/doi.org\/10.1016\/j.scr.2019.101536","relation":{},"ISSN":["1873-5061"],"issn-type":[{"value":"1873-5061","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stem cells preserve their stem cell traits after exposure to antimetabolite chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scr.2019.101536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101536"}}